Doral, FLNCT07459660Now EnrollingIRB Ready

Psychosis Associated With Alzheimer's Disease Clinical Trial in Doral, FL

Access cutting-edge psychosis associated with alzheimer's disease treatment through this clinical trial at a research site in Doral. Study-provided care at no cost to qualified participants.

Sponsored by MapLight Therapeutics

Quick Self-Assessment

See if you qualify for this Doral location

Preparing your pre-screening questions…

Expert Care in Doral

Access psychosis associated with alzheimer's disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related psychosis associated with alzheimer's disease treatment provided free

Apply for This Doral Location

Check if you qualify for this psychosis associated with alzheimer's disease clinical trial in Doral, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Doral

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Doral site if eligible
  4. 4Begin participation

About This Psychosis Associated With Alzheimer's Disease Study in Doral

ML-007C-MA-222 is a 52-week, flexible-dose, open-label extension study designed to evaluate the long-term safety, tolerability, and effectiveness of ML007C-MA in participants with ADP who have completed the antecedent study (ie, Study ML-007C-MA-221).

Sponsor: MapLight Therapeutics

Who Can Participate

Inclusion Criteria

Willing and able to provide written informed consent, or, if deemed lacking in the capacity to provide informed consent, the following requirements for consent must be met:
The participant's LAR must provide written informed consent. AND
The participant will provide informed assent.
Has completed the Double-Blind Treatment Period of an antecedent study with ML-007C-MA (ie, ML-007C-MA-221).
May benefit from long-term therapy with open-label ML-007C-MA treatment, in the judgment of the investigator.
Has a designated study care partner who is in contact with the participant frequently enough to accurately report on the participant's symptoms and adherence to study drug.
Resides in a stable living environment (eg, home, residential assisted living, or nursing home facility) and is expected to remain in the living situation throughout the study.

Exclusion Criteria

Under the care of hospice, bed-bound, or receiving end-of-life palliative care.
Requires treatment with protocol-defined prohibited medications.
Has developed a new or worsening medical comorbidity during or since the antecedent study that, in the opinion of the investigator and/or medical monitor, would compromise participant safety, interfere with the participant's ability to comply with study procedures, would preclude obtaining voluntary consent/assent, and/or would substantially impair the evaluation of study assessments.
Has or had a clinically significant abnormal physical examination, vital sign, ECG or clinical laboratory safety result during or since the antecedent study that would compromise participant safety, interfere with the participant's ability to comply with study procedures, and/or would confound the interpretation of the outcome measures in the study in the opinion of the investigator.
Has developed an allergy or other intolerance to ML-007C-MA, its active ingredients or their excipients since the antecedent study.
Has an elevated risk of suicidal behavior.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Doral?

Yes, this clinical trial (NCT07459660) has an active research site in Doral, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Psychosis Associated With Alzheimer's Disease Treatment Options in Doral, FL

If you're searching for psychosis associated with alzheimer's disease treatment options in Doral, FL, this clinical trial (NCT07459660) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Doral research site is actively enrolling participants for this clinical trial. You'll receive care from experienced psychosis associated with alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all psychosis associated with alzheimer's disease clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Doral, FL

See all alzheimers disease clinical trials recruiting in Doral — not just this study.

Browse Alzheimers Disease Trials in Doral →

Browse More Trials by Condition

Alzheimers Disease TrialsSchizophrenia TrialsAnkylosing Spondylitis TrialsErectile Dysfunction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Doral?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Doral, FL